尿路上皮癌抗体偶联药物靶点研究进展：NECTIN⁃4、HER⁃2与TROP⁃2的临床价值与未来挑战
张文涛, 刘勇强, 巫阳, 陈昊天, 郭亚东, 张俊峰, 毛士玉, 沈立亮, 马文超, 王瑞良, 许天源, 耿江, 沈兵, 姚旭东
Research progress on targets for antibody⁃drug conjugate in urothelial carcinoma: clinical value and future challenges of NECTIN⁃4,HER⁃2,and TROP⁃2
ZHANG Wentao, LIU Yongqiang, WU Yang, CHEN Haotian, GUO Yadong, ZHANG Junfeng, MAO Shiyu, SHEN Liliang, MA Wenchao, WANG Ruiliang, XU Tianyuan, GENG Jiang, SHEN
中国癌症防治杂志
.
2025, (6): 672
-682
.
DOI: 10.3969/j.issn.1674-5671.2025.06.04
